Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001181431-14-036913
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-20 09:16:11
Reporting Period:
2014-11-18
Filing Date:
2014-11-20
Accepted Time:
2014-11-20 09:16:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382911 Orexigen Therapeutics Inc. OREX Pharmaceutical Preparations (2834) 651178822
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1279735 C Louis Bock C/o Orexigen Therapeutics, Inc.
3344 N. Torrey Pines Court, Suite 200
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-18 625 $5.58 27,677 No 4 P Direct
Common Stock Acquisiton 2014-11-18 700 $5.58 700 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Spouse
Footnotes
  1. Shares purchased by the Reporting Person through an IRA Contributory Account.
  2. Shares purchased by, and for the benefit of, the Spouse of the Reporting Person through an IRA Contributory Account managed by the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person owns the shares for the purposes of Section 16 or any other purpose.